Sorrento Therapeutics, Inc. Class Action Lawsuit - SRNE

Company
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
Lead Plaintiff Deadline
July 27, 2020 (Expired)
Class Period
May 15, 2020 - May 22, 2020

Expired

Lead Plaintiff Deadline

Jul 27, 2020

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

(i) the Company’s initial finding of “100% inhibition” in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company’s finding was not a “cure” for COVID-19; and (ii) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Eligibility

In order to be eligible to join the SRNE class action lawsuit, you must have incurred a loss on shares of Sorrento purchased during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Sorrento during the relevant time frame or pursuant to the relevant offering(s), you have until July 27, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

TOP